Leeward Investments LLC MA Decreases Holdings in The Allstate Corporation $ALL

Leeward Investments LLC MA trimmed its stake in shares of The Allstate Corporation (NYSE:ALL) by 1.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 78,702 shares of the insurance provider’s stock after selling 1,546 shares during the period. Leeward Investments LLC MA’s holdings in Allstate were worth $15,844,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ALL. Price T Rowe Associates Inc. MD lifted its holdings in Allstate by 25.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,709,610 shares of the insurance provider’s stock valued at $2,424,710,000 after purchasing an additional 2,374,684 shares in the last quarter. Boston Partners raised its position in shares of Allstate by 613.9% in the first quarter. Boston Partners now owns 2,482,654 shares of the insurance provider’s stock valued at $512,627,000 after buying an additional 2,134,893 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Allstate by 27.2% in the first quarter. Goldman Sachs Group Inc. now owns 2,328,070 shares of the insurance provider’s stock valued at $482,073,000 after buying an additional 497,982 shares during the last quarter. Strs Ohio acquired a new stake in shares of Allstate in the first quarter valued at about $84,408,000. Finally, AQR Capital Management LLC raised its position in shares of Allstate by 20.3% in the first quarter. AQR Capital Management LLC now owns 2,018,403 shares of the insurance provider’s stock valued at $417,244,000 after buying an additional 340,150 shares during the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Price Performance

Shares of ALL opened at $193.37 on Friday. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.70. The stock has a market cap of $50.95 billion, a PE ratio of 9.09, a P/E/G ratio of 0.70 and a beta of 0.38. The firm has a 50-day simple moving average of $204.27 and a two-hundred day simple moving average of $201.08. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $5.94 earnings per share for the quarter, beating analysts’ consensus estimates of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $15.05 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same period last year, the business earned $1.61 earnings per share. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, analysts forecast that The Allstate Corporation will post 18.74 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ALL. Cantor Fitzgerald upgraded shares of Allstate to a “hold” rating in a research report on Wednesday, August 13th. Evercore ISI set a $233.00 target price on shares of Allstate and gave the company an “in-line” rating in a research report on Wednesday, October 1st. JPMorgan Chase & Co. increased their target price on shares of Allstate from $235.00 to $254.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. BMO Capital Markets raised their price objective on shares of Allstate from $230.00 to $235.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 20th. Finally, Wolfe Research upgraded shares of Allstate to a “strong-buy” rating in a research report on Tuesday, September 16th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $234.27.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.